IRIS International, Inc.
IRIS Acquires Bench-Top Instrument Platform for Automating (F)ISH Testing and Other Cytogenetic Applications
29. November 2010 16:01 ET | IRIS International, Inc.
CHATSWORTH, Calif., Nov. 29, 2010 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and a provider of high value personalized...
IRIS International, Inc.
IRIS International to Present at the 22nd Annual Piper Jaffray Health Care Conference on November 30, 2010
11. November 2010 07:00 ET | IRIS International, Inc.
CHATSWORTH, Calif., Nov. 11, 2010 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and...
IRIS International, Inc.
IRIS International Reports Record Third Quarter Revenue Fueled by Strong Instrument Sales and Record Consumables and Service Sales in Core Urinalysis Business
28. Oktober 2010 16:01 ET | IRIS International, Inc.
CHATSWORTH, Calif., Oct. 28, 2010 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), reflecting continued improved instrument sales and record sales of consumables and service in its Iris...
IRIS International, Inc.
IRIS to Release Third Quarter Financial Results and Host Conference Call and Webcast on Thursday, October 28, 2010
19. Oktober 2010 11:52 ET | IRIS International, Inc.
CHATSWORTH, Calif., Oct. 19, 2010 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), will release its third quarter 2010 financial results after the close of trading on Thursday, October 28,...
IRIS International, Inc.
IRIS to Present at Oppenheimer 21st Annual Healthcare Conference in New York, November 3, 2010
18. Oktober 2010 07:00 ET | IRIS International, Inc.
CHATSWORTH, Calif., Oct. 18, 2010 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and...
IRIS International, Inc.
IRIS International Granted European Patent for NADiA(R) Ultra-Sensitive Protein Detection and Cell Phenotyping Platform
14. Oktober 2010 07:00 ET | IRIS International, Inc.
CHATSWORTH, Calif., Oct. 14, 2010 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals...
IRIS International, Inc.
IRIS Appoints Amin I. Khalifa as Corporate Vice President and Chief Financial Officer
12. Oktober 2010 07:00 ET | IRIS International, Inc.
CHATSWORTH, Calif., Oct. 12, 2010 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and...
IRIS International, Inc.
IRIS Changes Name of Recently Acquired CLIA-Lab to Arista Laboratories, Inc.
07. Oktober 2010 07:00 ET | IRIS International, Inc.
CHATSWORTH, Calif., Oct. 7, 2010 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and...
IRIS International, Inc.
IRIS International Adopts Stockholder Rights Plan
27. September 2010 07:00 ET | IRIS International, Inc.
CHATSWORTH, Calif., Sept. 27, 2010 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostic systems and consumables for use in hospitals and...
IRIS International, Inc.
IRIS International CEO Cesar Garcia Discusses Company in Interview With The Wall Street Transcript
22. September 2010 07:00 ET | IRIS International, Inc.
CHATSWORTH, Calif., Sept. 22, 2010 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and...